Skip to main content

Day: September 30, 2021

LexaGene Reports on Recent Veterinary Trade Shows

BEVERLY, Mass., Sept. 30, 2021 (GLOBE NEWSWIRE) — LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a commercial molecular diagnostics company selling a point-of-need highly multiplexed in-clinic PCR system with results in approximately two hours, today provided an update on the three veterinary conferences attended by the Company in September. During the month of September, the Company exhibited at the WVC Annual Conference, the International Veterinary Emergency and Critical Care Conference (IVECCS), and the Southwest Veterinary Symposium (SWVS). Dr. Jack Regan, LexaGene’s CEO and Founder stated, “At these shows, we believe that we had one of the busiest booths due to the uniqueness of our technology. We are happy to report that during these shows and through our digital marketing campaign, we...

Continue reading

American Green (OTC:ERBB) Announces Its Official Launch on Groupon.com

Phoenix, AZ, Sept. 30, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — American Green is pleased to announce it has officially launched on GROUPON at American Green at Groupon.  Starting today, customers will be able to purchase vouchers directly from Groupon which can then be redeemed at AmericanGreenCBD.com. Groupon.com will serve as an additional outlet for the company’s manufacturing, marketing, and distribution of premium hemp and CBD products. According to American Green president, David Gwyther, “This launch is an important milestone for the company as we continue to add new, innovative ways to meet customers in places they trust and frequently visit.  Moreover, I believe that our agreement with Groupon demonstrates a true commitment to providing premium products at affordable prices.” The Groupon marketplace is known worldwide...

Continue reading

(OMHI) – OM Holdings International, Inc, Featured in USA Today on Tuesday, September 28, 2021

OMHI’s Sponsored Content Article Targets Prospective Investors as Part of Company’s Strategy to Educate Investors and Build Awareness OMHI’s DoGetGo App Plans to Improve Flow of Goods and Services for People and Companies in the IslandsMIAMI, FL , Sept. 30, 2021 (GLOBE NEWSWIRE) — OM Holdings International Inc. (OTC PINK: OMHI), an owner and operator of OneMart super merchandising stores and Builders Depot in the British Virgin Islands, and the parent of its technology subsidiary Rydeum, announced the company was featured in an article appearing in USA Today on September 28, 2021, as part of its sponsored content section.  The USA Today article is part of the company’s aggressive marketing strategy in educating investors about the company. The article entitled “OMHI announces multi-service, on-demand platform DoGetGo for the...

Continue reading

SL Green Inks New Lease With UiPath At One Vanderbilt Avenue

Trophy Office Tower Now Over 91% Leased NEW YORK, Sept. 30, 2021 (GLOBE NEWSWIRE) — SL Green Realty Corp. (NYSE: SLG), Manhattan’s largest office landlord, today announced that global enterprise automation software company, UiPath (NYSE: PATH), has signed a 15-year, 26,363-square-foot lease at One Vanderbilt Avenue covering the entire 60th floor. The skyline-defining tower in the heart of East Midtown is now over 91% leased. “We’re delighted to welcome UiPath to One Vanderbilt Avenue,” said Steven Durels, Executive Vice President and Director of Leasing and Real Property at SL Green. “They join a prestigious list of companies seeking a best-in-class, healthy work environment with direct connectivity to mass-transit.” “One Vanderbilt Avenue is one of those rare buildings that is quickly becoming a New York City icon, and we could...

Continue reading

Ultra Resources Announces Non-Brokered Private Placement of Up to C$6.0 Million, Including a C$3.3M Strategic Investment

Not for distribution to United States Newswire Services or for dissemination in the United States VANCOUVER, British Columbia, Sept. 30, 2021 (GLOBE NEWSWIRE) — Ultra Resources Inc. (TSX-V: ULT) (“Ultra Resources” or the “Company”) is pleased to announce a non-brokered private placement (the “Offering”) for aggregate gross proceeds to the Company of up to C$6.0 million from the sale of the following:units of the Company (the “Units”) at a price of C$0.15 per Unit ; and flow-through units of the Company (the “FT Units”) at a price of C$0.165 per FT UnitRed Cloud Securities Inc. is acting as a finder in connection with a portion of the Offering. Each Unit will be comprised of one common share of the Company (each, a “Unit Share”) and one half of one common share purchase warrant (each whole warrant, a “Warrant”). Each FT Unit...

Continue reading

Adaptive Biotechnologies Launches Enhanced clonoSEQ® Assay Reports for Patients with Chronic Lymphocytic Leukemia, Now Featuring IGHV Mutation Status

Combined ID-IGHV report at time of diagnosis conveniently provides additional prognostic information while also enabling future MRD monitoring in patients SEATTLE, Sept. 30, 2021 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, announced today the launch of an enhanced version of its clonoSEQ® B-cell Clonality (ID) report, which will now feature the immunoglobulin heavy chain (IgH) – V mutation status for patients with chronic lymphocytic leukemia (CLL). clonoSEQ is the first and only in vitro diagnostic cleared by the U.S. Food and Drug Administration (FDA) to detect and monitor minimal residual disease (MRD) in blood or bone marrow from patients...

Continue reading

Lincoln Electric Schedules Webcast for Third Quarter 2021 Results

CLEVELAND, Sept. 30, 2021 (GLOBE NEWSWIRE) — Lincoln Electric Holdings, Inc., (the “Company”) (Nasdaq: LECO) announced today that it will release its third quarter 2021 results on Thursday, October 28, 2021 prior to market open. An investor webcast will take place at 10:00 a.m. (ET) later that day. The earnings call will be webcast live in listen-only mode on the Company’s Investor Relations web site at https://ir.lincolnelectric.com. Listeners should go to the web site prior to the call to register, download and install any necessary audio software. If investors would like to ask questions, please dial (877) 344-3899 (domestic) or (315) 625-3087 (international) and use confirmation code 8735626. Telephone participants are asked to dial in 10 to 15 minutes prior to the start of the conference call.  A replay of the earnings...

Continue reading

Pacira Announces Commercial Production Underway with Enhanced EXPAREL Manufacturing Process at Swindon Facility

Marks key step in achieving EXPAREL gross margins that exceed 85 percent by 2024 PARSIPPANY, N.J., Sept. 30, 2021 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today announced that it has successfully completed process validation and EXPAREL® (bupivacaine liposome injectable suspension) commercial production is now underway at its custom 200-liter manufacturing suite in Swindon, England. The suite was developed under a partnership with Thermo Fisher Scientific Pharma Services. Pacira expects to begin selling commercial product manufactured in the 200-liter suite before the end of 2021. “The completion of our 200-liter validation process is a key milestone that doubles our manufacturing capacity to meet the growing...

Continue reading

OptimizeRx Appoints Seasoned Financial and Operational Executive, Edward Stelmakh as Chief Financial Officer and Chief Operations Officer

Doug Baker transitions to executive vice president of finance and accounting ROCHESTER, Mich., Sept. 30, 2021 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced the appointment of Edward Stelmakh as chief financial officer (CFO) and chief operating officer (COO) effective October 11th, 2021. He succeeds Doug Baker within the financial organization, who will continue as executive vice president of finance and accounting. “Ed’s extensive financial expertise, operational experience, and business analytics capabilities gained through years of leading the financial and operational teams of multiple growing public pharmaceutical companies are a great fit with our growing team, clients, and partners,” commented...

Continue reading

OpGen Initiates Clinical Trial for Unyvero Urinary Tract Infection Panel

OpGen’s Unyvero Urinary Tract Infection (UTI) Panel tests for a broad range of pathogens as well as antimicrobial resistance markers directly from native urine specimens Prospective multicenter trial plans to include samples collected from more than 1,500 U.S. patients Clinical performance evaluation aims at subsequent FDA submissionROCKVILLE, Md., Sept. 30, 2021 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, announced today that it has initiated the clinical trial for its Unyvero Urinary Tract Infection (UTI) Panel, which allows testing for a broad range of pathogens as well as antimicrobial resistance markers directly from native urine specimens. The Unyvero System and Unyvero Lower Respiratory...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.